Skip to main content

Table 1 Laboratory characteristics of the patient and relative family members in this study

From: A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency

 

PT

(s)

APTT

(s)

FDP

(mg/L)

DD

(mg/L)

AT:A

(%)

PC:A

(%)

PS:A

(%)

FPS:Ag

(%)

TPS:Ag

(%)

LAC

aCL

(PL/ml)

b2-GPI

(RU/ml)

FVII:A

(%)

FVII:Ag

(%)

FVIII:A

(%)

FIX:A

(%)

FX:A

(%)

vWF:A

(%)

Patient

28.1

32.9

1.5

0.35

102

104

86.3

99

111

1.1

3

5

2.6

3.4

163.4

149.9

71

158

Mother

15.0

30.8

1.3

0.23

114

110

94

100

120

1.1

5

7

63

58

145

149

80

143

Son

14.4

36.8

1.2

0.13

98

100

82

89

104

1.0

6

3

57

59

120

132

70

140

Daughter

13.1

28.7

2.0

0.21

96

98

86

94

121

1.0

3

3

68

62

126

112

68

136

Ref.

10

|

16

22.3

|

38.7

< 5

< 0.55

85

|

120

70

|

140

60

|

130

60

|

130

60

|

130

< 1.2

< 12

< 12

50

|

150

50

|

150

50

|

150

50

|

150

50

|

150

60

|

150

  1. PT, prothrombin time; APTT, activated partial thromboplastin time; FDP, fibrinogen degradation products; DD, D-dimer; AT, antithrombin; PC, protein C; PS, protein S; FPS, free protein S; TPS, total protein S; LAC, lupus anticoagulant; aCL, anticardiolipin antibody;β2-GPI, anti-β2 glycoprotein I; FVII, factor VII; FVII, factor VIII; FIX, factor IX; FX, factor X; vWF, von willebrand factor; A, activity; Ag, antigen; Ref., normal ranges for corresponding laboratory characteristics
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us